JucaBio
Clinical-stage biopharmaceutical company that acquires early‑stage therapeutic assets and builds focused subsidiary companies to advance those assets to value-inflection points. Employs a hub-and-spoke operating model and provides clinical development strategy, CMC and regulatory support, nonclinical and clinical operations, and business development to accelerate translation of novel therapeutics.
Industries
Nr. of Employees
small (1-50)
Services
Sourcing and acquiring early-stage therapeutic assets and creating focused subsidiaries to advance development.
Design and execution support for clinical development plans, trial design, CRO oversight and site management.
Process development, formulation, analytical development, manufacturing plant qualification and supply‑chain support for small molecules and biologics.
Regulatory dossier preparation, IND/NDA/BLA support, quality management system design and inspection readiness.
Design and coordination of IND‑enabling nonclinical studies, translational experiments and toxicology programs.
In-licensing negotiations, investor and partner engagement, and diligence support to inform portfolio decisions.
Sourcing and acquiring early-stage therapeutic assets and creating focused subsidiaries to advance development.
Design and execution support for clinical development plans, trial design, CRO oversight and site management.
Process development, formulation, analytical development, manufacturing plant qualification and supply‑chain support for small molecules and biologics.
Regulatory dossier preparation, IND/NDA/BLA support, quality management system design and inspection readiness.
Design and coordination of IND‑enabling nonclinical studies, translational experiments and toxicology programs.
In-licensing negotiations, investor and partner engagement, and diligence support to inform portfolio decisions.
Expertise Areas
- Clinical trial management
- Clinical pharmacology and translational science
- CMC and formulation development
- Analytical development and QC
Key Technologies
- GLP nonclinical studies
- Pharmacokinetics and drug metabolism assays
- Bioanalytical chemistry
- Analytical method development
News & Updates
Default site post: 'Welcome to WordPress. This is your first post. Edit or delete it, then start writing!'
Founding team members previously led a clinical-stage company through formation and acquisition by a large pharmaceutical company (acquisition completed in early 2023).
JucaBio was founded to build biotech portfolio companies and was established in April 2023.
Default site post: 'Welcome to WordPress. This is your first post. Edit or delete it, then start writing!'
Founding team members previously led a clinical-stage company through formation and acquisition by a large pharmaceutical company (acquisition completed in early 2023).
JucaBio was founded to build biotech portfolio companies and was established in April 2023.